| Metro Hospice West Valley Inc 7018 Owensmouth Ave, Ste 202, Canoga Park, CA, 91303 | |
| (818) 676-9695 |
News Archive
New research has shown that the corticosteroid deflazacort is a safe and effective treatment for Duchenne muscular dystrophy. The findings, which appear this month in the journal Neurology, could pave the way for first U.S.-approved treatment for the disease.
Thirteen national and international experts in the field of Brain Stimulation in Psychiatry and Neurology will meet October 7 and 8 during a conference held at the Douglas Mental Health University Institute. They will present research findings and ground-breaking clinical applications concerning the use of brain stimulation techniques. New treatments still under development, such as transcranial magnetic stimulation, will also be discussed. Close to 150 participants are expected to take part in this conference.
Cook Medical launched a new treatment option today for rhinologists (nose and sinus specialists) who treat patients that suffer from difficult-to-heal conditions in the nasal passages. The Biodesign ENT Repair Graft, which acts as an adjunct to aid in the natural healing process following nasal and sinus mucosal surgery, was introduced at the American Rhinologic Society's 2013 Summer Sinus Symposium. It is the latest Biodesign offering from Cook Medical's Otolaryngology-Head and Neck Surgery clinical division.
Compugen Ltd. today reported financial results for the third quarter ending September 30, 2011.
› Verified 3 days ago
| Name | Metro Hospice West Valley Inc |
|---|---|
| Location | 7018 Owensmouth Ave, Ste 202, Canoga Park, California |
| Hospice ID | 751656 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 200 |
News Archive
New research has shown that the corticosteroid deflazacort is a safe and effective treatment for Duchenne muscular dystrophy. The findings, which appear this month in the journal Neurology, could pave the way for first U.S.-approved treatment for the disease.
Thirteen national and international experts in the field of Brain Stimulation in Psychiatry and Neurology will meet October 7 and 8 during a conference held at the Douglas Mental Health University Institute. They will present research findings and ground-breaking clinical applications concerning the use of brain stimulation techniques. New treatments still under development, such as transcranial magnetic stimulation, will also be discussed. Close to 150 participants are expected to take part in this conference.
Cook Medical launched a new treatment option today for rhinologists (nose and sinus specialists) who treat patients that suffer from difficult-to-heal conditions in the nasal passages. The Biodesign ENT Repair Graft, which acts as an adjunct to aid in the natural healing process following nasal and sinus mucosal surgery, was introduced at the American Rhinologic Society's 2013 Summer Sinus Symposium. It is the latest Biodesign offering from Cook Medical's Otolaryngology-Head and Neck Surgery clinical division.
Compugen Ltd. today reported financial results for the third quarter ending September 30, 2011.
› Verified 3 days ago
| NPI Number | 1922447978 |
| Organization Name | Metro Hospice West Valley Inc. |
| Address | 7018 Owensmouth Ave Ste 202 Canoga Park, California, 91303 |
| Phone Number | (818)676-9695 |
News Archive
New research has shown that the corticosteroid deflazacort is a safe and effective treatment for Duchenne muscular dystrophy. The findings, which appear this month in the journal Neurology, could pave the way for first U.S.-approved treatment for the disease.
Thirteen national and international experts in the field of Brain Stimulation in Psychiatry and Neurology will meet October 7 and 8 during a conference held at the Douglas Mental Health University Institute. They will present research findings and ground-breaking clinical applications concerning the use of brain stimulation techniques. New treatments still under development, such as transcranial magnetic stimulation, will also be discussed. Close to 150 participants are expected to take part in this conference.
Cook Medical launched a new treatment option today for rhinologists (nose and sinus specialists) who treat patients that suffer from difficult-to-heal conditions in the nasal passages. The Biodesign ENT Repair Graft, which acts as an adjunct to aid in the natural healing process following nasal and sinus mucosal surgery, was introduced at the American Rhinologic Society's 2013 Summer Sinus Symposium. It is the latest Biodesign offering from Cook Medical's Otolaryngology-Head and Neck Surgery clinical division.
Compugen Ltd. today reported financial results for the third quarter ending September 30, 2011.
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
New research has shown that the corticosteroid deflazacort is a safe and effective treatment for Duchenne muscular dystrophy. The findings, which appear this month in the journal Neurology, could pave the way for first U.S.-approved treatment for the disease.
Thirteen national and international experts in the field of Brain Stimulation in Psychiatry and Neurology will meet October 7 and 8 during a conference held at the Douglas Mental Health University Institute. They will present research findings and ground-breaking clinical applications concerning the use of brain stimulation techniques. New treatments still under development, such as transcranial magnetic stimulation, will also be discussed. Close to 150 participants are expected to take part in this conference.
Cook Medical launched a new treatment option today for rhinologists (nose and sinus specialists) who treat patients that suffer from difficult-to-heal conditions in the nasal passages. The Biodesign ENT Repair Graft, which acts as an adjunct to aid in the natural healing process following nasal and sinus mucosal surgery, was introduced at the American Rhinologic Society's 2013 Summer Sinus Symposium. It is the latest Biodesign offering from Cook Medical's Otolaryngology-Head and Neck Surgery clinical division.
Compugen Ltd. today reported financial results for the third quarter ending September 30, 2011.
› Verified 3 days ago
| Home Health Aides | 3 |
| Counselors | 2 |
| Licensed Practical or Vocational Nurses | 2 |
| Medical Social Workers | 1 |
| Physicians | 2 |
| Registered Nurses | 2 |
| Total Employees | 12 |
|---|
News Archive
New research has shown that the corticosteroid deflazacort is a safe and effective treatment for Duchenne muscular dystrophy. The findings, which appear this month in the journal Neurology, could pave the way for first U.S.-approved treatment for the disease.
Thirteen national and international experts in the field of Brain Stimulation in Psychiatry and Neurology will meet October 7 and 8 during a conference held at the Douglas Mental Health University Institute. They will present research findings and ground-breaking clinical applications concerning the use of brain stimulation techniques. New treatments still under development, such as transcranial magnetic stimulation, will also be discussed. Close to 150 participants are expected to take part in this conference.
Cook Medical launched a new treatment option today for rhinologists (nose and sinus specialists) who treat patients that suffer from difficult-to-heal conditions in the nasal passages. The Biodesign ENT Repair Graft, which acts as an adjunct to aid in the natural healing process following nasal and sinus mucosal surgery, was introduced at the American Rhinologic Society's 2013 Summer Sinus Symposium. It is the latest Biodesign offering from Cook Medical's Otolaryngology-Head and Neck Surgery clinical division.
Compugen Ltd. today reported financial results for the third quarter ending September 30, 2011.
› Verified 3 days ago
| Others | 2 |
| Total Volunteers | 2 |
|---|
News Archive
New research has shown that the corticosteroid deflazacort is a safe and effective treatment for Duchenne muscular dystrophy. The findings, which appear this month in the journal Neurology, could pave the way for first U.S.-approved treatment for the disease.
Thirteen national and international experts in the field of Brain Stimulation in Psychiatry and Neurology will meet October 7 and 8 during a conference held at the Douglas Mental Health University Institute. They will present research findings and ground-breaking clinical applications concerning the use of brain stimulation techniques. New treatments still under development, such as transcranial magnetic stimulation, will also be discussed. Close to 150 participants are expected to take part in this conference.
Cook Medical launched a new treatment option today for rhinologists (nose and sinus specialists) who treat patients that suffer from difficult-to-heal conditions in the nasal passages. The Biodesign ENT Repair Graft, which acts as an adjunct to aid in the natural healing process following nasal and sinus mucosal surgery, was introduced at the American Rhinologic Society's 2013 Summer Sinus Symposium. It is the latest Biodesign offering from Cook Medical's Otolaryngology-Head and Neck Surgery clinical division.
Compugen Ltd. today reported financial results for the third quarter ending September 30, 2011.
› Verified 3 days ago
| Gentle Care Hospice, Inc Location: 22148 Sherman Way, Ste 200, Canoga Park, California, 91303 Phone: (818) 676-9695 |
| True Care Hospice, Inc. Location: 7355 Topanga Canyon Blvd, Suite 100, Canoga Park, California, 91303 Phone: (818) 676-9695 |
| Excellence Hospice Care, Inc Location: 21133 Victory Blvd, Ste 215, Canoga Park, California, 91303 Phone: (818) 676-9695 |
| Metro Hospice West Valley Inc Location: 7018 Owensmouth Ave, Ste 202, Canoga Park, California, 91303 Phone: (818) 676-9695 |